Industry News

Biotechnology Summit Participants Address Variety of Issues

Published in Gene Therapy Weekly, March 6th, 1995

U.S. Food and Drug Administration (FDA) reform, shortages of capital, gene therapy, bioethical issues and the danger of defunding research hospitals were key issues on the part of participants at the second National Biotechnology Summit, Washington, D.C., held January 12, 1995.

BioEast '95 was sponsored by Genetic Engineering News and joined by the Biotechnology Industry Organization (BIO), indicated reporter David Holzman ("FDA Reform and Shortage of Capital Top Themes Examined at National Biotech Summit," Genetic Engineering News, February 1, 1995;15(3):1;12).

Holzman quoted Kathryn Zoon, Ph.D., director of the FDA's Center for Biologics and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (1995-03-06)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry